Alnylam is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.

Cosmo Oil Co., Ltd. engages in the petroleum bulk stations and terminals business. It also operates in oil procurement and manufacture, distribution, import and export of oil and petrochemical products. The company was founded on April 1, 1986 and is headquartered in Tokyo, Japan.

Hoechst Schering AgrEvo GmbH was a Düsseldorf-based limited liability company owned by Hoechst AG and Schering AG that only existed as an independent company for five years, from 1994 to 1999. It was established in 1994, when two German producers of chemicals and pharmaceuticals, Hoechst and Schering, merged their crop protection divisions into a new joint venture to benefit from economies of scale in marketing and research and development. In 1999, AgrEvo’s majority shareholder, Hoechst, merged with the French pharmaceutical and chemical company Rhône-Poulenc to become Aventis, with AgrEvo and Rhône-Poulenc's agrochemicals division combined into Aventis CropScience. In 2002, Bayer AG acquired Aventis CropScience and combined it with their agrochemicals division (Bayer Pflanzenschutz or "Crop Protection") to form Bayer CropScience.

Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Kyowa Hakko Bio Co. Ltd. engages in the manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use. The company was founded on October 1, 2008 and is headquartered in Tokyo, Japan.

Bayer CropScience is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. People at Bayer CropScience are committed to help tackle challenges with their expertise in high value seeds, innovative chemical and biological crop protection solutions, and services for modern, sustainable agriculture. Their daily work – in the lab and on the ground – focuses on how they can help farmers across the globe overcome their challenges. With the “head of a scientist” and the “heart of a farmer” they bring innovative and inspiring solutions directly to their customers, along with reliable services and advice. And thus support food production where it begins: on the field.

KYUNG NONG Corp. engages in the manufacture and distribution of agricultural chemical products. Its products include fungicide, insecticide, herbicide, and plant growth regulator. The company was founded on July 12, 1957 and is headquartered in Seoul, South Korea.

Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.

Impossible Foods focuses on developing plant-based substitutes for meat, dairy, and fish products. It selects specific proteins and nutrients from greens, seeds, and grains to recreate the experience of meats and dairy products. Founded by Patrick Brown and Monte Casino in 2011, Impossible Foods is headquartered in Redwood City, California.

Shanghai and Different Technology Co., Ltd., established on 2019-04-12, The scope of business includes engaging in precision instruments,information Technology,internet of things,Measurement and control equipment,Technology transfer in the field of new material science and technology,Technical Services,technical consulting,technology development,business management,marketing planning,business inquiries,Market information consultation and investigation(Do not engage in social investigation,social research,poll,opinion poll),Cultural and artistic exchange planning,public event planning,commercial service,IoT system,precision instrument,Measurement and control equipment,Sales of new materials,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Tianjin Hubin Pangu Gene Science Development Co., Ltd., established on 2014-05-07, Business scope includes gene technology and biological product research and development,technology transfer,technical consulting,Technical Services;medical instruments,drug development,Technology Consulting and Transfer;Biological product(food,except medicines)Wholesale and retail;Engage in import and export business permitted by national laws and regulations;account Serive.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Road Synthetic Enterprise Management Co., Ltd., established on 2019-04-17, Business scope includes business management;Business Management Consulting;Technical Services,technical consulting,technology development,Technology Promotion,technology transfer;buisness planning,design.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)